A series of studies presented last month at the American Society of Clinical Oncology, one of the largest gatherings of cancer researchers, adds to a growing body of evidence suggesting GLP-1 use may reduce one's risk
In the PIONEER clinical trials, mean HbA1c reductions ranged from approximately 0.7% to 1.3%, depending on the dose and baseline characteristics
The compounding pharmacies aren't making these active ingredients themselves
Patients with active cancer, certain bleeding disorders, pregnancy, or untreated systemic conditions are not candidates regardless of how strong the recovery interest is
Strategies to manage end-of-week hunger include ensuring adequate protein and fiber intake, maintaining regular meal timing, and discussing with your physician whether dose adjustment is appropriate